F. Coussy et al.
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
Journal of Hematology & Oncology 2020, vol. 13, issue 1
doi: 10.1186/s13045-020-0846-y
![Logo France Génomique](https://www.france-genomique.org/wp-content/uploads/2019/03/logo-FG-blue-RVB-medium.png)
F. Coussy et al.
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
Journal of Hematology & Oncology 2020, vol. 13, issue 1
doi: 10.1186/s13045-020-0846-y